aladdin 阿拉丁 I177384 Ipragliflozin,抑制剂 761423-87-4 97%

中文名：Ipragliflozin,抑制剂

英文名：Ipragliflozin

中文别名：(1S)-1,5-脱水-1-C-[3-[(1-苯并噻吩-2-基)甲基]-4-氟苯基]-D-葡糖醇

英文别名：Ipragliflozin|761423-87-4|suglat|ASP1941|ASP-1941|Ipragliflozin [INN]|Ipragliflozin (ASP1941)|(2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol|3N2N8OOR7X|CHEMBL2018096|(1S)-1,5-Anhydro-1-c-[3-[(1-benzot

纯度：97%

货号：I177384

包装：100mg、25mg、10mg

Cas号：761423-87-4

存储温度：-20°C储存

产品介绍：

Ipragliflozin (ASP1941) is a highly potent and selective SGLT2 inhibitor with IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6. IC50 value: 2.8 nM Target: SGLT2 in vitro: Ipragliflozin potently and selectively inhibited human, rat, and mouse SGLT2 at nanomolar ranges and exhibited stability against intestinal glucosidases. in vivo: Ipragliflozin showed good pharmacokinetic properties following oral dosing, and dose-dependently increased urinary glucose excretion, which lasted for over 12 h in normal mice. Oral administration of ipragliflozin increased urinary glucose excretion in a dose-dependent manner, an effect which was significant at doses of 0.3 mg/kg or higher and lasted over 12 h. Single administration of ipragliflozin dose-dependently increased urinary glucose excretion, reduced blood glucose and plasma insulin levels, and improved glucose intolerance .

查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/I177384.html